CA Stock MarketDetailed Quotes
MYCO Mydecine Innovations Group Inc
- 0.020
- +0.010+100.00%
15min DelayTrading Jul 12 12:21 ET
1.24MMarket Cap-16P/E (TTM)
0.020High0.015Low9.08KVolume0.020Open0.010Pre Close171.51Turnover0.20052wk High0.02%Turnover Ratio61.76MShares0.01052wk Low-1.2EPS TTM1.24MFloat Cap0.200Historical HighLossP/E (Static)61.76MShs Float0.010Historical Low-1.34EPS LYR50.00%Amplitude--Dividend TTM-0.19P/B1Lot Size--Div YieldTTM
About Mydecine Innovations Group Inc Company
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Company Profile
SymbolMYCO
Company NameMydecine Innovations Group Inc
Founded2013
MarketCNQ
Employees3
Fiscal Year Ends12-31
Address789 West Pender Street Suite 810
CityVancouver
CountryCAN
Zip CodeV6C 1H2
Phone+1 604 687-2038
Websitehttps://www.mydecine.com
Company Executives
- Name
- Position
- Salary
- David Joshua Bartch
- Director and Chief Executive Officer
- --
- Dean Ditto
- Chief Financial Officer
- --
- Damon Michaels
- Director and Chief Operating Officer
- --
- Robert Roscow
- Director and Chief Scientific Officer
- --
- Dr. Rakesh Jetly
- Chief Medical Officer
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg